Evidence map›Paper›PMID 27615403›Full record

ArticleDrug and alcohol dependence2016

Behavioral risk assessment for infectious diseases (BRAID): Self-report instrument to assess injection and noninjection risk behaviors in substance users.

Kelly E Dunn, Frederick S Barrett, Evan S Herrmann, Jennifer G Plebani, Stacey C Sigmon, Matthew W Johnson

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Kelly E DunnBehavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine Department of Psychiatry and Behavioral Sciences, 5510 Nathan Shock Drive, Baltimore, MD, 21224, United States. Electronic address: kdunn9@jhmi.edu.
Frederick S BarrettBehavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine Department of Psychiatry and Behavioral Sciences, 5510 Nathan Shock Drive, Baltimore, MD, 21224, United States.
Evan S HerrmannNew York State Psychiatric Institute, United States.
Jennifer G PlebaniUniversity of Pennsylvania Department of Psychiatry, Treatment Research Center, United States.
Stacey C SigmonUniversity of Vermont College of Medicine, Department of Psychiatry, United States.
Matthew W JohnsonBehavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine Department of Psychiatry and Behavioral Sciences, 5510 Nathan Shock Drive, Baltimore, MD, 21224, United States.
Behavioral Pharma (United States) · USJohns Hopkins University · USNew York State Psychiatric InstituteUniversity of Pennsylvania · USUniversity of Vermont · US

Funding

HUMAN BEHAVIORAL PHARMACOLOGY OF SUBSTANCE ABUSET32DA007209 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Eric C. Strain, Elise M Weerts · 1985 to 2026
$12.9M
Translational Clinical Research Fellowship on Substance Use DisordersT32DA007294 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Frances Rudnick Levin, Diana M Martinez · 1993 to 2026
$9.3M
A118G SNP and OPRM1 Gene Opioid-Mediated Effects in HumansR01DA035246 · NIDA · JOHNS HOPKINS UNIVERSITY · PI DUNN, KELLY E · 2014 to 2018
$3.2M
Varenicline for the treatment of cocaine dependence: Phase IIU01DA032629 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI KAMPMAN, KYLE MATTHEW · 2012 to 2016
$3.0M
Development of a Prospective Memory Intervention to Reduce Drug Use and HIV RiskR01DA035277 · NIDA · JOHNS HOPKINS UNIVERSITY · PI JOHNSON, MATTHEW WAYNE · 2013 to 2018
$2.0M
Role of delay discounting in driving HIV sexual risk behavior in cocaine abuseR01DA032363 · NIDA · JOHNS HOPKINS UNIVERSITY · PI JOHNSON, MATTHEW WAYNE · 2012 to 2014
$959k
Interim Treatment: Leveraging buprenophine + technology to bridge waitlist delaysR34DA037385 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SIGMON, STACEY C · 2014 to 2015
$652k
Development and Validation of a Computerized Opioid Overdose InterventionR21DA035327 · NIDA · JOHNS HOPKINS UNIVERSITY · PI DUNN, KELLY E · 2013 to 2014
$446k
NIDA NIH HHS R01 DA032363NIDA NIH HHS R01 DA035246NIDA NIH HHS R01 DA035277NIDA NIH HHS R21 DA035327NIDA NIH HHS R34 DA037385NIDA NIH HHS T32 DA007209NIDA NIH HHS T32 DA007294NIDA NIH HHS U01 DA032629
6 · The paper itself

Abstract

backgroundInfectious diseases such as Human Immunodeficiency Virus and Hepatitis C are a significant problem among substance abusers. Current risk behavior measures [e.g., HIV Risk Taking Behaviour Scale (HRBS) and Risk Assessment Battery (RAB)] were developed for injection drug users and do not include newly identified risks or noninjection drug use behaviors. This study developed and provided initial, internal validation of the Behavioral Risk Assessment for Infectious Diseases (BRAID) to assess infectious disease risk behaviors among alcohol and other drug users.

methodsA self-report measure was developed from literature regarding risk behaviors. Participants (total N=998) with alcohol/substance use disorder completed the measure in 2 phases to establish initial psychometric validity.

resultsPhase 1 (N=270) completed 65 self-report questions; factor analysis revealed a 12-item solution with 5 factors (Unprotected Sex with Risky Partners, Injection Use, Sex on Cocaine/Crack, Condom Availability, and Intranasal Drug Use). Infectious disease history was positively associated with Injection Use (Sample 1) and Unprotected Sex with Risky Partners (Sample 2) and negatively associated with Intranasal Drug Use (Samples 1 and 2). Phase 2 (N=728) added additional injection-related items and confirmed the factor structure of the existing BRAID.

conclusionsThe BRAID is a 5-factor, 14-item self-report measure of past 6 month risk behaviors that is composed of noninjection and injection risk behaviors and was psychometrically confirmed. Though additional external (convergent/divergent) validation is needed, this report provides preliminary support for the use of the BRAID to assess infectious disease risk in substance users.

Indexed as

Risk-TakingAdolescentAdultAgedAged, 80 and overCondomsCrack CocaineDrug UsersFemaleHepatitis CHIV InfectionsHumansMaleMiddle AgedRisk AssessmentSelf ReportCrack CocaineBRAIDDrug use disorderHIVInjectionNoninjection

Identifiers

PMID27615403
PMCPMC5086299
OpenAlexW2511855081

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.